ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,509.01
      0.62%
      US Tech 100
      19,480.00
      0.00%
      Dow Jones
      39,331.85
      0.00%
      Brent Oil
      86.085
      -0.42%
      Bitcoin
      60,209.84
      -2.93%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Antares Pharma Inc (ATRS)

      7. Antares Pharma Inc (ATRS) News

      ATRS

      Antares Pharma (ATRS)

      Antares Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRS
      DateTimeSourceHeadlineSymbolCompany
      11:19AMiHub NewswireFeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth
      03/13/20147:00AMBusiness WireAntares Pharma Reports Fourth Quarter and Full Year 2013 Operating and Financial ResultsNASDAQ:ATRSAntares Pharma Inc
      03/12/20147:00AMBusiness WireAntares Pharma Receives Second Milestone Payment from LEO Pharma in OTREXUP CollaborationNASDAQ:ATRSAntares Pharma Inc
      03/11/201410:17AMPR Newswire (US)Medac Pharma, Inc. Announces the Issuance of U.S. Patent for Treating Autoimmune Diseases with Concentrated Methotrexate Solu...NASDAQ:ATRSAntares Pharma Inc
      03/10/20147:00AMBusiness WireAntares Pharma Announces LEO Pharma’s Launch of OTREXUP (Methotrexate) Injection to Dermatologists for Adults with PsoriasisNASDAQ:ATRSAntares Pharma Inc
      03/06/20147:00AMBusiness WireAntares Pharma to Host Fourth Quarter 2013 Operating and Financial Results Conference CallNASDAQ:ATRSAntares Pharma Inc
      02/26/20147:00AMBusiness WireAntares Pharma to Present at the Cowen and Company 34th Annual Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      02/24/20145:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      02/20/20149:44AMDow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNASDAQ:ATRSAntares Pharma Inc
      02/20/20147:00AMBusiness WireAntares Pharma Announces Positive Results from the VIBEX QuickShot Pharmacokinetic Study in Testosterone Deficient MenNASDAQ:ATRSAntares Pharma Inc
      02/19/20147:00AMBusiness WireAntares Pharma to Participate in the 2014 RBC Capital Markets’ Global Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      02/14/20142:08PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRSAntares Pharma Inc
      02/13/20144:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ATRSAntares Pharma Inc
      01/15/20147:00AMBusiness WireAntares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis ...NASDAQ:ATRSAntares Pharma Inc
      01/06/20141:00PMBusiness WireAntares Pharma to Present at the 32nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      12/20/20137:00AMBusiness WireAntares Pharma® Announces Notice of Allowance for New Patent on Reconstitutable Lyophilized InjectablesNASDAQ:ATRSAntares Pharma Inc
      12/04/20137:00AMBusiness WireAntares Pharma to Present at the Oppenheimer 24th Annual Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      11/26/20137:00AMBusiness WireAntares Pharma Announces Additional U.S. Patent Protection for OTREXUP™NASDAQ:ATRSAntares Pharma Inc
      11/19/20137:00AMBusiness WireAntares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical DevelopmentNASDAQ:ATRSAntares Pharma Inc
      11/15/20138:39AMDow Jones NewsKingdon Capital Management 3Q 13F: Holdings As Of -2-NASDAQ:ATRSAntares Pharma Inc
      11/15/20138:39AMDow Jones NewsKingdon Capital Management 3Q 13F: Largest PurchasesNASDAQ:ATRSAntares Pharma Inc
      11/15/20138:39AMDow Jones NewsKingdon Capital Management 3Q 13F: Holdings As Of Sep 30NASDAQ:ATRSAntares Pharma Inc
      11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest EliminationsNASDAQ:ATRSAntares Pharma Inc
      11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest SalesNASDAQ:ATRSAntares Pharma Inc
      11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-NASDAQ:ATRSAntares Pharma Inc
      11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-NASDAQ:ATRSAntares Pharma Inc
      11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest PurchasesNASDAQ:ATRSAntares Pharma Inc
      11/15/20138:12AMDow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-NASDAQ:ATRSAntares Pharma Inc
      11/14/20139:00AMBusiness WireAntares Pharma Enters into an Exclusive U.S. Promotion and Marketing Agreement with LEO Pharma for OTREXUP™ in DermatologyNASDAQ:ATRSAntares Pharma Inc
      11/06/20135:20PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:ATRS